ARCHIVES

Symposium Addresses FCC issues

This article is from The Cancer Letter archive.

Vol. 12 No. 08 | February 21, 1986

Download PDF Visit The Full Archive

Related Articles

Letters: Kopans To Broder: Response Ignores Major Questions

October 15, 1993

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists

November 14, 1975

Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA.

November 22, 2006

Letter to the Editor: IOM Study Welcome For “Omic” Research

October 29, 2010

DCCP Board Gives Concept Approval To RFA For Biochemical Epidemiolgy, New And Recompeting Contract Program

September 23, 1983